{
  "id": 14566907,
  "title": "Iambic, an AI drug discovery specialist, banks $150M in an IPO",
  "url": "https://urgent.news/2026/10/15/iambic-an-ai-drug-discovery-specialist-banks-150m-in-an-ipo",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-15T00:08:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/iambic-ipo-price-ai-drug-discovery/832771/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Part of a wave of young biotechs employing AI to accelerate research, the company claimed in regulatory filings that its approach has the potential to “disrupt legacy drug discovery paradigms.”",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}